We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The World Health Organization (WHO) has launched a pilot program aimed at increasing insulin access by prequalifying biotherapeutic products that contain human insulin as an active ingredient. Read More
NICE said that the cost-effectiveness estimates of the combination are higher than what it normally considers an acceptable use of National Health Service resources. Read More